Search Results 411-420 of 14816 for albumin

  1. Gastroenterology and Hepatology - Clinical trials

    This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...

  2. NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS - Mayo Clinic

    ... albumin, or fetal bovine serum. Other: - Is a pregnant or lactating female. Eligibility last updated 8/22/23. Questions regarding updates should be directed ...

  3. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

    Serum albumin ≥ 2 g/dL. Adequate cardiac function defined as: Left ventricular fractions (LVEF) ≥ 50% as determined by a multigated acquisition (MUGA) ...

  4. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    - Albumin, S > 1.5 x ULN (within 30 days of randomization). - Protein, total, S > 1.5 x ULN (within 30 days of randomization). - Creatinine > 1.5 x ULN ...

  5. Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Mayo Clinic

    Albumin; Glucose; Fibrinogen; Electrocardiogram (ECG). REGISTRATION STEP 2-RANDOMIZATION: Patients must have complete history and physical examination within 28 ...

  6. Factor ix (intravenous route, injection route) - Side effects & dosage - Mayo Clinic

    Substance Name. Factor IX Albumin Fusion Protein Recombinant. There are no adequate studies in women for determining infant risk when using this medication ...

  7. Study of VS-6766 + Adagrasib in KRAS G12C NSCLC Patients - Mayo Clinic

    Albumin ≥3.0 g/dL (451 μmol/L);; Creatine phosphokinase (CPK) ≤ 2.5 x ULN;; Adequate cardiac function with left ventricular ejection fraction ≥ 50% by ...

  8. Clinical Trials - IS-002 in Prostate Cancer

    Albumin: < LLN;; Hepatic function at screening: AST and/or ALT: > 2.5 x ULN;; Total Bilirubin (serum): >1.5 x ULN. 4. Subject has received neo-adjuvant ...

  9. Study of Pembrolizumab Combined with Decitabine and Pralatrexate in Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma - Mayo Clinic

    ≤ 2.5 X ULN OR ≤ 5 X ULN for subjects with liver metastases. Albumin. > 2.5 mg/dL. Coagulation. International Normalized Ratio (INR) or Prothrombin Time (PT).

  10. Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary - Mayo Clinic

    Albumin > 2.5 g/dL; Females of childbearing potential must have a negative serum pregnancy test within 72 hours prior to registration. NOTE: If the urine ...